Almonty Industries – 2025-12-16 - increase Confidence 6/10

ALM – increase in Days/Weeks

Almonty Industries reported a $58.2 million net loss in Q2 2025 due to non-cash derivative charges, yet simultaneously raised US$90 million in new equity capital. Shares rose 9.1% the prior day, and technical indicators now signal a short-term buy.

Why This Matters

While the company continues to burn cash and carries a high debt/equity ratio (115.1), the successful US$90 million financing alleviates near-term liquidity concerns and funds critical expansion at Panasqueira and Gentung Browns Lake. This capital infusion, combined with Almonty’s strategic positioning in tungsten—a critical defense and tech metal—provides a fundamental counterweight to weak profitability, supporting investor sentiment in the short term.

Key Insights

• Financial Signal: Negative free cash flow (TTM: -$43.7M) and gross margin pressure (5.39%) reflect operational challenges.
• News Impact: US$90M public offering strengthens balance sheet and validates growth strategy, acting as a positive catalyst.
• Risk/Offset: High leverage (Debt/Equity: 115.1) and analyst downgrade to “Hold” (C$10.00 target) cap near-term upside.

Practical Implications

• Bull Case: Fresh capital drives investor confidence and project momentum, pushing price toward C$10.00 target (+25% from current).
• Bear Case: Continued losses and dilution concerns could trigger sell-off if tungsten prices weaken or execution lags.
• Confidence: 6/10 – Strong catalyst and technical signal offset weak fundamentals in short window.

Prediction: increase

Reference:

• https://www.theglobeandmail.com/investing/markets/stocks/ALM-Q/pressreleases/34191623/almonty-industries-reports-q2-2025-financial-results-and-strategic-developments/
• https://www.benzinga.com/trading-ideas/movers/25/12/49395988/kyverna-therapeutics-immunome-almonty-industries-and-other-big-stocks-moving-higher-on-monday